BE665076A - - Google Patents

Info

Publication number
BE665076A
BE665076A BE665076A BE665076A BE665076A BE 665076 A BE665076 A BE 665076A BE 665076 A BE665076 A BE 665076A BE 665076 A BE665076 A BE 665076A BE 665076 A BE665076 A BE 665076A
Authority
BE
Belgium
Prior art keywords
sep
gelatin
degraded
oxypolygelatin
crosslinked
Prior art date
Application number
BE665076A
Other languages
English (en)
French (fr)
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from BE641705A external-priority patent/BE641705A/fr
Application filed filed Critical
Priority to BE665076A priority Critical patent/BE665076A/fr
Publication of BE665076A publication Critical patent/BE665076A/fr

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K39/0016Combination vaccines based on diphtheria-tetanus-pertussis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K39/02Bacterial antigens
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K39/02Bacterial antigens
    • A61K39/102Pasteurellales, e.g. Actinobacillus, Pasteurella; Haemophilus
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/315Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Streptococcus (G), e.g. Enterococci
    • C07K14/3153Streptokinase
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00Microorganisms; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/04Preserving or maintaining viable microorganisms
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/96Stabilising an enzyme by forming an adduct or a composition; Forming enzyme conjugates
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/42Proteins; Polypeptides; Degradation products thereof; Derivatives thereof, e.g. albumin, gelatin or zein
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/08Solutions
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02ATECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Microbiology (AREA)
  • Genetics & Genomics (AREA)
  • Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Wood Science & Technology (AREA)
  • Biotechnology (AREA)
  • Mycology (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Immunology (AREA)
  • Veterinary Medicine (AREA)
  • Biochemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Virology (AREA)
  • Biomedical Technology (AREA)
  • General Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biophysics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Medicinal Preparation (AREA)
BE665076A 1963-12-23 1965-06-08 BE665076A (de)

Priority Applications (1)

Application Number Priority Date Filing Date Title
BE665076A BE665076A (de) 1963-12-23 1965-06-08

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
BE641705A BE641705A (de) 1963-12-23 1963-12-23
BE665076A BE665076A (de) 1963-12-23 1965-06-08

Publications (1)

Publication Number Publication Date
BE665076A true BE665076A (de) 1965-12-08

Family

ID=25655617

Family Applications (1)

Application Number Title Priority Date Filing Date
BE665076A BE665076A (de) 1963-12-23 1965-06-08

Country Status (1)

Country Link
BE (1) BE665076A (de)

Cited By (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2371927A1 (en) * 1976-11-29 1978-06-23 Connaught Lab Anti:poliomyelitis vaccine contg. attenuated viruses - is stabilised by suspending in tris-hydroxy-methyl-amino-methane and L-cystine opt. with acid hydrolysed gelatin
FR2425245A1 (fr) * 1978-05-12 1979-12-07 Sumitomo Chemical Co Procede pour la preparation d'une composition injectable d'urokinase
EP0006671A3 (en) * 1978-07-03 1980-02-06 Hans Dr. Ing. Muller Process for the conservation of living microorganisms
EP0028563A1 (de) * 1979-10-29 1981-05-13 Merck & Co. Inc. Stabilisator für flüssige Impfstoffe und diesen Stabilisator enthaltender flüssiger Impfstoff

Cited By (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2371927A1 (en) * 1976-11-29 1978-06-23 Connaught Lab Anti:poliomyelitis vaccine contg. attenuated viruses - is stabilised by suspending in tris-hydroxy-methyl-amino-methane and L-cystine opt. with acid hydrolysed gelatin
FR2425245A1 (fr) * 1978-05-12 1979-12-07 Sumitomo Chemical Co Procede pour la preparation d'une composition injectable d'urokinase
EP0006671A3 (en) * 1978-07-03 1980-02-06 Hans Dr. Ing. Muller Process for the conservation of living microorganisms
EP0028563A1 (de) * 1979-10-29 1981-05-13 Merck & Co. Inc. Stabilisator für flüssige Impfstoffe und diesen Stabilisator enthaltender flüssiger Impfstoff

Similar Documents

Publication Publication Date Title
BE897276A (fr) Compositions d'interferon b stales et procede de stabilisation l'interferon b
CH656534A5 (fr) Procede pour stabiliser un facteur de necrose tumorale et solution aqueuse ou poudre stables contenant ce facteur.
US4206200A (en) Stabilizer for polysaccharides
BE1001533A3 (fr) Vaccin vivant attenue stabilise et sa fabrication.
EP0841942B1 (de) Verfahren zur industriellen herstellung eines japanischen enkephalitis impfstoffes, und so erhaltener impfstoff
FR2475900A1 (fr) Complexe vaccinal contenant un antigene specifique et vaccin le contenant
EP0353108B2 (de) Verfahren zur Stabilisierung von Impfstoffen, Assoziationen von attenuierten, lyophilisierten Impfstoffen und erhaltene Zusammensetzungen
BE1008163A5 (fr) Nouveaux oligodesoxyribonucleotides a activite anti-ischemique et leur preparation.
EP0013851A1 (de) Gereinigte bakterielle Proteoglycane, Verfahren zu ihrer Herstellung und sie enthaltender Impfstoff
BE665076A (de)
EP0252059A2 (de) Stabilisatoren für abgeschwächte Impfstoffe, Verfahren zu deren Herstellung und Impfstoffe, die diese enthalten
EP0071515B1 (de) Verfahren zur Herstellung von Kapselpolyosiden, so erhaltene Kapselpolyosiden und ihre Verwendung für die Herstellung von Vakzinen
EP1357895A2 (de) Impfstoffzusammensetzung und stabilisierungsverfahren
JPH0228319B2 (de)
Gardner et al. Relative stability of pertussis vaccine preserved with merthiolate, benzethonium chloride, or the parabens
CH412201A (fr) Procédé de stabilisation d'un produit à base de virus antigène labile
EP1981549B1 (de) Verfahren zur inaktivierung von viren durch trockene hitze
EP0383645A1 (de) Verfahren zur Herstellung von antihämophilem Faktor (Faktor VIII), der eine hohe Reinheit aufweist.
BE896383A (fr) Procede pour stabiliser un facteur de necrose tumorale et solution aqueuse ou poudre stables contenant ce facteur
BE641705A (de)
CH423098A (fr) Procédé de préparation d'un vaccin staphylococcique
AU2005203171B2 (en) Botulinum toxin pharmaceutical compositions
BE622212A (de)
EP0106831A2 (de) Stämme des Rinderdiarrhöevirus, ihre Herstellung und diese enthaltende Vakzine
WO1997002044A1 (fr) Conservateur pour composition vaccinale